XML 15 R38.htm IDEA: XBRL DOCUMENT v3.19.3
Borrowings - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Dec. 07, 2018
Sep. 30, 2017
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2017
Debt Instrument [Line Items]              
Warrants issued to purchase redeemable convertible preferred stock     461,273   461,273    
Number of common shares to be called upon exercise of warrants     512,363   512,363    
Series F redeemable convertible preferred stock              
Debt Instrument [Line Items]              
Number of common shares to be called upon exercise of warrants   104,722          
Loan payable | Capital Royalty Partners II LP              
Debt Instrument [Line Items]              
Loan repayment             $ 17,800
2017 Term loan | Loan payable              
Debt Instrument [Line Items]              
Term loan, issuance costs   $ 100          
2017 Term loan | Loan payable | Innovatus Life Sciences Lending Fund              
Debt Instrument [Line Items]              
Term loan borrowings $ 5,000 20,000          
Term loan, interest rate     1100.00%   1100.00%    
Term loan, paid in-kind, interest rate     250.00%   250.00%    
Term loan, effective interest rate     1400.00%   1400.00%    
Term loan, fee incurred upon payment of final installment     $ 1,000   $ 1,000    
Term loan, prepayment premium percentage     3.00%   3.00%    
Term loan, annual reduction in prepayment penalty percentage     100.00%   100.00%    
Term loan covenant, interest only milestones, increase to interest rate     800.00%   800.00%    
Term loan covenant, minimum issuance of equity securities and subordinated debt     $ 9,500   $ 9,500    
Term loan covenant, minimum unrestricted cash balance     $ 2,000   $ 2,000    
Term loan covenant, increase to interest rate     400.00%   400.00%    
Term loan, issuance costs   $ 400          
2017 Term loan | Loan payable | Innovatus Life Sciences Lending Fund | Series F redeemable convertible preferred stock              
Debt Instrument [Line Items]              
Warrants issued to purchase redeemable convertible preferred stock 3,846,154 15,384,615          
Warrants issued to purchase redeemable convertible preferred stock, exercise price (in dollars per share)   $ 0.078          
Number of common shares to be called upon exercise of warrants   104,722          
2017 Term loan | Paid in-kind note | Innovatus Life Sciences Lending Fund              
Debt Instrument [Line Items]              
Term loan, paid in-kind loans issued     $ 200 $ 100 $ 500 $ 400